About Polaris Oligonucleotides

This startup specializes in the synthesis of custom oligonucleotides, DNA-encoded libraries, and bioconjugates to support advanced oligonucleotide research. By providing tailored synthetic solutions, the company addresses the need for precise and complex nucleic acid constructs in various scientific applications.

```xml <problem> Researchers require custom oligonucleotides, DNA-encoded libraries, and bioconjugates with specific modifications and high purity for advanced research applications. Obtaining these specialized nucleic acid constructs can be challenging due to the complexity of synthesis and the need for precise control over chemical modifications. </problem> <solution> This company provides custom synthesis of oligonucleotides, DNA-encoded libraries (DELs), and bioconjugates, enabling researchers to obtain precisely tailored nucleic acid constructs. They offer a range of services, including custom oligonucleotide modifications, custom nucleobase synthesis, and oligo bioconjugations. By specializing in complex and customized synthesis, the company addresses the need for high-quality, specialized reagents in advanced research applications. Their services support researchers in various fields by providing the necessary tools for cutting-edge experiments. </solution> <features> - Custom oligonucleotide synthesis with a wide range of modifications - Synthesis of DNA-encoded libraries (DELs) for drug discovery and other applications - Oligo bioconjugation services for attaching various molecules to oligonucleotides - Custom nucleobase synthesis for specialized research needs - DNA ladders and ancillary reagents for molecular biology applications - Academic rebate program available </features> <target_audience> The primary customers are researchers in academia, biotechnology, and pharmaceutical companies who require custom oligonucleotides, DNA-encoded libraries, and bioconjugates for their research. </target_audience> ```

What does Polaris Oligonucleotides do?

When was Polaris Oligonucleotides founded?

Polaris Oligonucleotides was founded in 2022.

Founded

2022

Employees

2 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Polaris Oligonucleotides

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

polarisoligos.com 100+

Founded 2022

Funding

No funding information available.

Team (<5)

No team information available.

Company Description

Problem

Researchers require custom oligonucleotides, DNA-encoded libraries, and bioconjugates with specific modifications and high purity for advanced research applications. Obtaining these specialized nucleic acid constructs can be challenging due to the complexity of synthesis and the need for precise control over chemical modifications.

Solution

This company provides custom synthesis of oligonucleotides, DNA-encoded libraries (DELs), and bioconjugates, enabling researchers to obtain precisely tailored nucleic acid constructs. They offer a range of services, including custom oligonucleotide modifications, custom nucleobase synthesis, and oligo bioconjugations. By specializing in complex and customized synthesis, the company addresses the need for high-quality, specialized reagents in advanced research applications. Their services support researchers in various fields by providing the necessary tools for cutting-edge experiments.

Features

Custom oligonucleotide synthesis with a wide range of modifications

Synthesis of DNA-encoded libraries (DELs) for drug discovery and other applications

Oligo bioconjugation services for attaching various molecules to oligonucleotides

Custom nucleobase synthesis for specialized research needs

DNA ladders and ancillary reagents for molecular biology applications

Academic rebate program available

Target Audience

The primary customers are researchers in academia, biotechnology, and pharmaceutical companies who require custom oligonucleotides, DNA-encoded libraries, and bioconjugates for their research.